A Convergence Directorate at the National Science Foundation
Summary
Convergence is a compelling novel paradigm and a potent force for advancing scientific discovery via transdisciplinary collaboration. It is also a useful framework for multi-sector partnerships. The Biden-Harris Administration should form a Convergence Directorate at the National Science Foundation (NSF) to accelerate research and innovation and help ensure U.S. leadership in the industries of the future.
In forming the Directorate, NSF should:
- Commit resources that are commensurate with the importance of the Directorate’s mission.
- Provide the sustained focus needed to realize the tremendous potential of convergence.
- Ensure that the Directorate is organized to reflect the principles of convergence in its structure and operations.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.